| scholarly article | Q13442814 |
| P2093 | author name string | Jones SD | |
| Calin A | |||
| Steiner A | |||
| Garrett SL | |||
| P433 | issue | 1 | |
| P921 | main subject | ankylosing spondylitis | Q52849 |
| patient | Q181600 | ||
| P304 | page(s) | 66-71 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | British Journal of Rheumatology | Q27709787 |
| P1476 | title | The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). | |
| P478 | volume | 35 |
| Q47359648 | A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity |
| Q57623434 | A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis |
| Q43937874 | A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis |
| Q92891195 | ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis |
| Q41451166 | Adaptation of Chinese and English versions of the Ankylosing Spondylitis quality of life (ASQoL) scale for use in Singapore |
| Q84092250 | Adaptation of Turkish version of the questionnaire Quick Disability of the Arm, Shoulder, and Hand (Quick DASH) in patients with carpal tunnel syndrome |
| Q80559990 | Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS |
| Q50545386 | Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. |
| Q51728489 | Aerobic capacity and its correlates in patients with ankylosing spondylitis. |
| Q45764344 | Ankylosing spondylitis presenting to a chiropractic office: a report of two cases |
| Q50858149 | Aortic root disease and valve disease associated with ankylosing spondylitis. |
| Q83140635 | Assessment of efficacy of pamidronate in undifferentiated spondyloarthropathy (uSpA): a placebo control trial in a tertiary level center |
| Q39091689 | Assessment of fatigue in Moroccan patients with ankylosing spondylitis. |
| Q84651102 | Association of Bone Morphogenetic Proteins with Spinal Fusion in Ankylosing Spondylitis |
| Q79190170 | Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan |
| Q48315650 | Association of cigarette smoking with Chinese ankylosing spondylitis patients in Taiwan: a poor disease outcome in systemic inflammation, functional ability, and physical mobility |
| Q64279030 | AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS) |
| Q57623469 | Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum |
| Q36992933 | Cardiac Autonomic Function in Patients With Ankylosing Spondylitis: A Case-Control Study |
| Q34222218 | Combined home exercise is more effective than range-of-motion home exercise in patients with ankylosing spondylitis: a randomized controlled trial. |
| Q45240252 | Complementary and alternative medicines in ankylosing spondylitis: a cross-sectional study |
| Q48148670 | Decreased physical activity and cardiorespiratory fitness in adults with ankylosing spondylitis: a cross-sectional controlled study. |
| Q80462005 | Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing |
| Q35880376 | Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. |
| Q51820032 | Development of a prognostic score for work disability in Romanian patients with ankylosing spondylitis. |
| Q53114781 | Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort. |
| Q58797988 | Diffusion-weighted imaging versus short tau inversion recovery sequence: Usefulness in detection of active sacroiliitis and early diagnosis of axial spondyloarthritis |
| Q92237446 | Disease Activity, Occupational Participation, and Quality of Life for Individuals with and without Severe Fatigue in Ankylosing Spondylitis |
| Q35555116 | Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis |
| Q43527556 | Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort |
| Q34650355 | Effects of glossopharyngeal insufflation in ankylosing spondylitis: a pilot study |
| Q35551784 | Employment perspectives of patients with ankylosing spondylitis |
| Q35550292 | Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients |
| Q79739231 | Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan |
| Q88463163 | Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage |
| Q82601024 | Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis |
| Q82548050 | Evaluation of the Turkish version of the Bath Ankylosing Spondylitis Patient Global Score (BAS-G) |
| Q47800988 | Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with ankylosing spondylitis |
| Q34608115 | Evaluation of the short-term efficacy of NSAIDs on patients with active ankylosing spondylitis in daily practice: a 3-month, longitudinal, observational study |
| Q48398415 | Fatigue in patients with ankylosing spondylitis: relationships with disease-specific variables, depression, and sleep disturbance |
| Q92505093 | Fatty corner lesions in T1-weighted magnetic resonance imaging as an alternative to sacroiliitis for diagnosis of axial spondyloarthritis |
| Q51162191 | Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. |
| Q53037194 | Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis. |
| Q38974892 | Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China |
| Q45852300 | Gender differences in Iranian patients with ankylosing spondylitis. |
| Q40523969 | Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study |
| Q35553676 | Health status of patients with ankylosing spondylitis: a comparison with the general population |
| Q36454463 | Health-related Quality of Life Assessment on 100 Tunisian Patients with Ankylosing Spondylitis using the SF-36 Survey |
| Q34117039 | Identification of RGS1 as a candidate biomarker for undifferentiated spondylarthritis by genome-wide expression profiling and real-time polymerase chain reaction |
| Q50929219 | Improving the standard of care for people with ankylosing spondylitis and a new approach to developing specialist ESP-Led AS clinics. |
| Q35638180 | Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis |
| Q37191464 | Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study |
| Q34805243 | Infrared sauna in patients with rheumatoid arthritis and ankylosing spondylitis. A pilot study showing good tolerance, short-term improvement of pain and stiffness, and a trend towards long-term beneficial effects |
| Q89521441 | Intensity of spinal inflammation is associated with radiological structural damage in patients with active axial spondyloarthritis |
| Q33314436 | Internet-based randomised controlled trials for the evaluation of complementary and alternative medicines: probiotics in spondyloarthropathy |
| Q81341899 | Intravenous application of omega-3 fatty acids in a patient with active spondylarthropathy--a case report |
| Q39954736 | Living with Ankylosing Spondylitis: the patient's perspective. |
| Q53818059 | Local infliximab injection of sacroiliac joints in non-radiographic axial spondyloarthritis: Impact on clinical and magnetic resonance imaging parameters of disease activity. |
| Q38010372 | Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylos |
| Q53451579 | Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging. |
| Q36245947 | Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment |
| Q40401248 | Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort |
| Q54094549 | Periodontal condition is associated with disease duration and motoric disabilities in patients with ankylosing spondylitis: results of a cross-sectional study. |
| Q57672929 | Portuguese version of the bath indexes for ankylosing spondylitis patients: a cross-cultural adaptation and validation |
| Q44077285 | Prevalence and associated risk factors for work disability in Egyptian patients with ankylosing spondylitis from one center |
| Q89414707 | Prevalence and factors associated with disturbed sleep in outpatients with ankylosing spondylitis |
| Q48023845 | Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases |
| Q35071645 | Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis |
| Q39410595 | Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis. |
| Q61805810 | Psychometric validation of the EuroQoL 5-dimension (EQ-5D) questionnaire in patients with spondyloarthritis |
| Q58052021 | Pulmonary function in ankylosing spondylitis: association with clinical variables |
| Q39513524 | Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population |
| Q53279948 | Relationship between diet and ankylosing spondylitis: A systematic review. |
| Q81557411 | Relative contributions of the ribcage and abdomen to lung volume displacement during speech production |
| Q34014598 | Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii |
| Q83816591 | Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients |
| Q39476642 | Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis. |
| Q40709174 | Sexual dysfunctions and lower urinary tract symptoms in ankylosing spondylitis |
| Q50910626 | Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status. |
| Q60050041 | Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study |
| Q84682802 | Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation |
| Q47211643 | Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). |
| Q90610397 | Test-retest repeatability of the apparent diffusion coefficient in sacroiliac joint MRI in patients with axial spondyloarthritis and healthy individuals |
| Q35838797 | The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment |
| Q47149814 | The McMaster Toronto Arthritis patient preference questionnaire (MACTAR): a methodological study of reliability and minimal detectable change after a 6 week-period of acupuncture treatment in patients with rheumatoid arthritis |
| Q80514383 | The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity |
| Q80330363 | The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity |
| Q36925535 | The assessment of ankylosing spondylitis in clinical practice. |
| Q41362640 | The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility |
| Q34507570 | The information needs of people living with ankylosing spondylitis: a questionnaire survey |
| Q49721192 | The nocebo effect challenges the non-medical infliximab switch in practice. |
| Q40415336 | The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study |
| Q82165544 | The relationship between severity and extent of spinal involvement and spinal mobility and physical functioning in patients with ankylosing spondylitis |
| Q60910081 | Traditional Chinese medicine (TCM) collaborative care for patients with axial spondyloarthritis (AcuSpA): protocol for a pragmatic randomized controlled trial |
| Q47187728 | Translation, cultural adaptation, and validation of the Bath questionnaires and HAQ-S in Hindi for Indian patients with ankylosing spondylitis |
| Q49946686 | Using Self-Reported Patient Experiences to Understand Patient Burden: Learnings from Digital Patient Communities in Ankylosing Spondylitis. |
| Q47653401 | Validity and sensitivity to change of the Patient Specific Functional Scale used during rehabilitation following proximal humeral fracture |
| Q38748204 | Valuing treatment with infliximab for ankylosing spondylitis using a willingness-to-pay approach |
| Q38139808 | Variables related to work productivity loss in patients with ankylosing spondylitis |
| Q44499471 | What factors determine patients' preference for tumour necrosis factor inhibitors in ankylosing spondylitis? |
| Q47146126 | Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study. |
| Q35549928 | Withdrawal from labour force due to work disability in patients with ankylosing spondylitis |
| Q46205113 | Work disability in ankylosing spondylitis: differences among working and work-disabled patients. |
| Q84600024 | [Effectiveness of biological agents in ankylosing spondylitis] |
| Q82678823 | [Outcome parameters in ankylosing spondylitis] |
| Q37631508 | rs657075 (CSF2) Is Associated with the Disease Phenotype (BAS-G) of Ankylosing Spondylitis |
Search more.